Garbe, C., Keim, U., Amaral, T., Berking, C., Eigentler, T., Flatz, L., . . . Lorigan, P. C. (2022). Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts: Implications for adjuvant treatment. Journal of clinical oncology, 40(32), . https://doi.org/10.1200/JCO.22.00202
Chicago Style (17th ed.) CitationGarbe, Claus, et al. "Prognosis of Patients with Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment." Journal of Clinical Oncology 40, no. 32 (2022). https://doi.org/10.1200/JCO.22.00202.
MLA (9th ed.) CitationGarbe, Claus, et al. "Prognosis of Patients with Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment." Journal of Clinical Oncology, vol. 40, no. 32, 2022, https://doi.org/10.1200/JCO.22.00202.